Forum Discussion
Groundbreaking genomic test could spare millions of breast cancer patients chemotherapy
I wonder if there were any members ON the Optima Trial? The Optima trial, led by University College London, followed more than 4,000 patients with newly diagnosed breast cancer in the UK, Norway, ...
Thank you for sharing this arpie and bringing light to this important topic - it is always exciting and hopeful to see what potential treatments can be made available with research. Our Policy & Advocacy director Vicki Durston has been following this closely - check her latest post here